Skip to main content
Log in

Species Differences in the Selective Inhibition of Monoamine Oxidase (1-methyl-2-phenylethyl)hydrazine and its Potentiation by Cyanide

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The potentiating effects of cyanide on the inhibition of rat liver mitochondrial monoamine oxidase-A & B and of ox liver mitochondrial MAO-B by pheniprazine [(1-methyl-2-phenylethyl)hydrazine] has been studied. Pheniprazine was shown to behave as a mechanism-based MAO inhibitor. For rat liver MAO-B, the initial non-covalent step was characterized by dissociation constant (K i) of 2450 nM and the first-order rate constant (k +2) for the covalent adduct formation was 0.16 min−1. As a reversible inhibitor it was selective towards rat liver MAO-A (K i = 420 nM) but the rate of irreversible inhibition of that enzyme was considerably slower (k +2 =  0.06 min−1). MAO-B from ox liver more closely resembled MAO-A from the rat in sensitivity to reversible inhibition by pheniprazine (K i = 450 nm) but it was closer to rat liver MAO-B in rate of irreversible inhibition (k +2 = 0.29 min−1). The K i values were significantly decreased in the presence of KCN but there was little effect on the k +2 values. However, sensitivities of the different enzymes to KCN varied widely and considerably higher concentrations of KCN were required for this effect to be apparent with the rat liver mitochondrial MAO-A than with MAO-B from rat and ox liver. The kinetic behaviour of cyanide activation was consistent with partial (non-essential) competitive activation in all cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Tipton KF (1989) Monoamine oxidase inhibitors as antidepressants. In: Tipton KF, Youdim MBH (eds) Biochemical and pharmacological aspects of depression. Taylor & Francis, London, pp 1–24

    Google Scholar 

  2. Patek DR, Hellerman L (1974) Mitochondrial monoamine oxidase: mechanism of inhibition by phenylhydrazine and aralkylhydrazine. Role of enzymatic oxidation. J Biol Chem 249:2373–2380

    PubMed  CAS  Google Scholar 

  3. Kenny WC, Nagy J, Salach JI, Singer TP (1979). Structure of the covalent phenylhydrazine adduct of monoamine oxidase. In: Singer TP, von Korff RW, Murphy DL (eds) Monoamine oxidase: Structure, function and altered functions. Academic Press, New York, pp 1–24

    Google Scholar 

  4. Davison AN (1957) The mechanism of the irreversible inhibition of rat liver monoamine oxidase by iproniazid (Marsilid). Biochem J 67:316–322

    PubMed  CAS  Google Scholar 

  5. Ben Ramadan Z, Dostert P, Tipton KF (1999) Some peculiar aspects of monoamine oxidase inhibition. Neurobiology 7:159–174

    Google Scholar 

  6. Houslay MD, Tipton KF (1973) The reaction pathway of rat liver monoamine oxidase. Biochem J 135:173–186

    PubMed  CAS  Google Scholar 

  7. Tipton KF, Spires IPC (1972). The kinetics of phenethylhydrazine oxidation by monoamine oxidase. Biochem J 125:521–524

    Google Scholar 

  8. Yu PH, Tipton KF (1989). Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity. Biochem Pharmacol 38:4245–4251

    Article  PubMed  CAS  Google Scholar 

  9. Salach JI (1979) Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties and determination of its cysteinyl flavin content Arch. Biochem Biophys 192:128–137

    Article  CAS  Google Scholar 

  10. Tipton KF, Davey GP, Motherway M (2000) Monoamine oxidase assays. In: Enna SJ, Willias M, Ferkany JW, Kenakin T, Porsolt RE, Sullivan JP (eds) Current protocols in pharmacology. John Wiley, New York, pp 3.6.1–3.6.42

    Google Scholar 

  11. Tian WX, Tsou CL (1982) Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry 21:1028–1032

    Article  PubMed  CAS  Google Scholar 

  12. Tipton KF (2001) Enzymes: Irreversible inhibition. Encyclopedia of life sciences. http://www.els.net/[doi:10.1038/npg.els.0000601], John Wiley, New York

  13. Tipton KF (2003) Enzyme activities. In: Davey J, Lord JM (eds) Essential cell biology: Cell function, vol. 2 (practical approach). Oxford University Press, pp 1–46

  14. Walsh CT (1982) Suicide substrates: Mechanism-based enzyme inactivators. Tetrahedron 38:871–909

    Article  CAS  Google Scholar 

  15. Fowler CJ, Mantle TJ, Tipton KF (1982) The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol 31:3555–3561

    Article  PubMed  CAS  Google Scholar 

  16. Garrick NA, Murphy DL (1982) Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology 72:27–33

    Article  Google Scholar 

  17. Reid AA, Hill JL, Murphy DL (1988) Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B. Naunyn-Schmiedeberg’s Arch Pharmacol 388:678–683

    Article  Google Scholar 

  18. Krueger MJ, Mazouz F, Ramsay RR, Milcent R, Singer TP (1995) Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors. Biochem Biophys Res Commun 206:556–562

    Article  PubMed  CAS  Google Scholar 

  19. O’Brien EM, Dostert P, Tipton KF (1995) Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B. Biochem Pharmacol 50:317–324

    Article  PubMed  CAS  Google Scholar 

  20. Hubalek F, Binda C, Khalil A, Li M, Mattevi A, Castagnoli N, Edmondson DE (2005). Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors. J Biol Chem 280:15761–15766

    Article  PubMed  CAS  Google Scholar 

  21. Hubalek F, Pohl J, Edmondson DE (2003) Structural comparison of human monoamine oxidases A and B. Mass spectrometry monitoring of cysteine reactivities. J Biol Chem 278:28612–28618

    Article  PubMed  CAS  Google Scholar 

  22. Kenney WC, Nagy J, Salach JI, Singer TP (1979) Structure of the covalent phenylhydrazine adduct of monoamine oxidase. In: Singer TP, Von Korff RW, Murphy DL (eds) Monoamine oxidase: Structure, function and altered functions. Academic Press, New York, pp 25–37

    Google Scholar 

  23. Valley MP, Tichy SE, Fitzpatrick PF (2005) Establishing the kinetic competency of the cationic imine intermediate in nitroalkane oxidase. J Am Chem Soc 127:2062–2066

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to the Health Research Board and Forbairt, Ireland, for support for this work, to the Government of Libya for a grant in support of ZBR and to the EC ERASMUS Programme for the support of MLW.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keith F. Tipton.

Additional information

Special issue dedicated to Dr. Moussa Youdim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramadan, Z.B., Wrang, M.L. & Tipton, K.F. Species Differences in the Selective Inhibition of Monoamine Oxidase (1-methyl-2-phenylethyl)hydrazine and its Potentiation by Cyanide. Neurochem Res 32, 1783–1790 (2007). https://doi.org/10.1007/s11064-007-9309-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-007-9309-x

Keywords

Navigation